Curaleaf Holdings, Inc. is a leading producer and distributor of consumer products in the cannabis industry. The company operates a business that is vertically integrated and includes cultivation, processing, manufacturing, and retail dispensaries across the United States and select international markets. It emphasizes quality, expertise, and reliability while serving both medical and adult use consumers through a portfolio of branded products such as Curaleaf, Find, JAMS, Grassroots, Select, and Zero Proof seltzers. Curaleaf was an early entrant into the U. S. state legal cannabis industry and continues to expand its footprint in limited license states. The company provides industry leading services, product selection and accessibility across the medical and adult use markets in the United States. The Company leverages its extensive research and development capabilities to distribute cannabis products with the highest standard for safety, effectiveness, consistent quality and customer care. The Company is committed to leading the industry in education and advocacy through research and advocacy.

Revenue is generated primarily from the sale of cannabis derived products, including flower, edibles, oils, concentrates, and infused beverages, to medical patients and adult use customers. The company sells these products through its own dispensary network and via wholesale channels to third party retailers and distributors. Additional income streams include licensing arrangements, manufacturing services for third parties, and medical clinic services in the United Kingdom. A significant portion of revenue comes from the adult use market, while medical cannabis sales also contribute substantially to total sales. Wholesale sales to third party distributors and international partners represent a growing portion of the company’s total revenue. Revenue streams are diversified across product categories, including flower, edibles, oils, concentrates, and infused beverages, and across geographic markets in the United States and internationally. Adult use sales constitute a significant portion of revenue, while medical cannabis sales also contribute meaningfully to total sales.

The company operates through the following segments: Domestic operations and International operations.

• Domestic operations: This segment encompasses the cultivation, processing, and sale of medical and adult use cannabis in 15 U. S. states, operating 151 dispensaries, 19 cultivation sites, and 20 processing facilities, and includes the company’s brand portfolio of Curaleaf, Find, JAMS, Grassroots, Select, and Zero Proof seltzers. The states in which Curaleaf conducts domestic operations include Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Missouri, Nevada, New Jersey, New York, North Dakota, Ohio, Pennsylvania, and Utah. Curaleaf has partnered with an accredited medical school and obtained a clinical registrant license in Pennsylvania to support its medical cannabis offerings. In each of these states, Curaleaf holds licenses for both medical and adult use cannabis cultivation, processing, and retail sales.

• International operations: This segment covers licensed cultivation in Portugal and Canada, pharma grade manufacturing in Germany, Spain, Canada, Portugal and the United Kingdom, distribution channels in Germany, Poland, Canada, Switzerland and the United Kingdom, a medical cannabis clinic and pharmacy license in the United Kingdom, and wholesale supply to Australia, New Zealand and various European markets including Germany, Italy, Poland, Czech Republic, Switzerland, Sweden and Norway. Curaleaf also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and across Europe, including Germany, Italy, Poland, Czech Republic, Switzerland, Sweden and Norway. The pharma grade manufacturing facilities in Europe produce cannabinoid based pharmaceutical products for medical use. Distribution channels in Germany, Poland, Canada, Switzerland and the United Kingdom supply these products to pharmacies and healthcare providers.

Curaleaf Holdings, Inc. ranks among the largest multi state cannabis operators in the United States by dispensary count and revenue, benefiting from its early market entry, vertical integration, and focus on limited license states. The company’s competitive advantages include a broad brand portfolio, extensive cultivation capacity, and a diversified geographic footprint that reduces reliance on any single market. Its integrated model allows control over product quality from seed to sale, which supports consistent customer experience and brand loyalty. The company is known for quality, expertise and reliability in the cannabis industry. The company’s brand portfolio is recognized for consistency and trust among consumers and regulators. Curaleaf’s focus on limited license states provides a competitive barrier to entry for new operators.

Curaleaf Holdings, Inc. serves medical patients and adult use consumers through its dispensary network, as well as wholesale customers such as distributors and retailers in the United States and abroad. The company also provides medical cannabis directly to patients via its clinic in the United Kingdom. Internationally, Curaleaf supplies wholesale cannabis to countries such as Germany, Italy, Poland, Czech Republic, Switzerland, Sweden and Norway, and maintains distribution partnerships in Canada and Switzerland. The company serves a diverse customer base that includes individual consumers, business clients, and international partners seeking reliable cannabis products. The company’s retail dispensaries serve individual consumers seeking medical relief or recreational enjoyment, while its wholesale operations support business clients ranging from independent retailers to large distributors.